Research ArticleOriginal Research

Evidence-Based Selection of Candidates for the Levonorgestrel Intrauterine Device (IUD)

Lisa S. Callegari, Blair G. Darney, Emily M. Godfrey, Olivia Sementi, Rebecca Dunsmoor-Su and Sarah W. Prager
The Journal of the American Board of Family Medicine January 2014, 27 (1) 26-33; DOI: https://doi.org/10.3122/jabfm.2014.01.130142

References

  1. 1.↵
    1. Finer LB,
    2. Zolna MR
    . Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011;84:478–85.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Finer LB,
    2. Henshaw SK
    . Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90–6.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Trussell J
    . Contraceptive failure in the United States. Contraception 2011;83:397–404.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Peipert JF,
    2. Zhao Q,
    3. Allsworth JE,
    4. et al
    . Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105–13.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Winner B,
    2. Peipert JF,
    3. Zhao Q,
    4. et al
    . Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998–2007.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Allen RH,
    2. Goldberg AB,
    3. Grimes DA
    . Expanding access to intrauterine contraception. Am J Obstet Gynecol 2009;201:456.e1–5.
    OpenUrlPubMed
  7. 7.↵
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Long-Acting Reversible Contraception Working Group. ACOG Committee Opinion no. 450: Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol 2009;114:1434–8.
    OpenUrlPubMed
  8. 8.↵
    1. Turok DK
    . What the world needs now is more access to the levonorgestrel IUD. Contraception 2013;87:391–2.
    OpenUrlPubMed
  9. 9.↵
    1. Lowe RF,
    2. Prata N
    . Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic review. Contraception 2013;87:486–96.
    OpenUrlPubMed
  10. 10.↵
    1. Kadir RA,
    2. Chi C
    . Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy. Contraception 2007;75(6 Suppl):S123–9.
    OpenUrlPubMed
  11. 11.↵
    1. Pakarinen P,
    2. Luukkainen T
    . Treatment of menorrhagia with an LNG-IUS. Contraception 2007;75(6 Suppl):S118–22.
    OpenUrlPubMed
  12. 12.↵
    1. Gemzell-Danielsson K,
    2. Schellschmidt I,
    3. Apter D
    . A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012;97:616–22.e1–3.
    OpenUrlPubMed
  13. 13.↵
    1. Hubacher D,
    2. Grimes DA
    . Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002;57:120–8.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Mirena package insert. Wayne, NJ: Bayer HealthCare Pharmaceutials Inc; February 2013. Available from: http://labeling.bayerhealthcare.com/html/products/pi/Mirena_PI.pdf. Accessed July 15, 2013.
  15. 15.↵
    Centers for Disease Control and Prevention (CDC). US medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep 2010;59(RR-4):1–86.
    OpenUrlPubMed
  16. 16.↵
    Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group; American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2012;120:983–8.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Stanwood NL,
    2. Garrett JM,
    3. Konrad TR
    . Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 2002;99:275–80.
    OpenUrlPubMed
  18. 18.↵
    1. Madden T,
    2. Allsworth JE,
    3. Hladky KJ,
    4. Secura GM,
    5. Peipert JF
    . Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists' knowledge and attitudes. Contraception 2010;81:112–6.
    OpenUrlPubMed
  19. 19.↵
    1. Harper CC,
    2. Blum M,
    3. de Bocanegra HT,
    4. et al
    . Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet Gynecol 2008;111:1359–69.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Rubin SE,
    2. Fletcher J,
    3. Stein T,
    4. Segall-Gutierrez P,
    5. Gold M
    . Determinants of intrauterine contraception provision among US family physicians: a national survey of knowledge, attitudes and practice. Contraception 2011;83:472–8.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Espey E,
    2. Ogburn T,
    3. Espey D,
    4. Etsitty V
    . IUD-related knowledge, attitudes and practices among Navajo Area Indian Health Service providers. Perspect Sex Reprod Health 2003;35:169–73.
    OpenUrlPubMed
  22. 22.↵
    1. Harper CC,
    2. Henderson JT,
    3. Raine TR,
    4. et al
    . Evidence-based IUD practice: family physicians and obstetrician-gynecologists. Fam Med 2012;44:637–45.
    OpenUrlPubMed
  23. 23.↵
    1. Hosmer DW,
    2. Lemeshow S
    . Applied logistic regression. 2nd ed. New York: Wiley; 2000.
  24. 24.↵
    1. Kooiker CH,
    2. Scutchfield FD
    . Barriers to prescribing the Copper T 380A intrauterine device by physicians. West J Med 1990;153:279–82.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    1. Tyler CP,
    2. Whiteman MK,
    3. Zapata LB,
    4. Curtis KM,
    5. Hillis SD,
    6. Marchbanks PA
    . Health care provider attitudes and practices related to intrauterine devices for nulliparous women. Obstet Gynecol 2012;119:762–71.
    OpenUrlPubMed
  26. 26.↵
    1. Grol R,
    2. Grimshaw J
    . From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225–30.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Cabana MD,
    2. Rand CS,
    3. Powe NR,
    4. et al
    . Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458–65.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Kohn JE,
    2. Hacker JG,
    3. Rousselle MA,
    4. Gold M
    . Knowledge and likelihood to recommend intrauterine devices for adolescents among school-based health center providers. J Adolesc Health 2012;51:319–24.
    OpenUrlPubMed
  29. 29.↵
    1. Rubin SE,
    2. Davis K,
    3. McKee MD
    . New York City physicians' views of providing long-acting reversible contraception to adolescents. Ann Fam Med 2013;11:130–6.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Cull WL,
    2. O'Connor KG,
    3. Sharp S,
    4. Tang SF
    . Response rates and response bias for 50 surveys of pediatricians. Health Serv Res 2005;40:213–26.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Dillman DA,
    2. Smyth JD,
    3. Christian LM
    . Internet, mail, and mixed-mode surveys: the tailored design method. 3rd ed. Hoboken, NJ: Wiley & Sons; 2009.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords